Skip to main content

Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

Johnson & Johnson Will Pay $6.5 Billion to Settle Talc Ovarian Cancer Lawsuits

THURSDAY, May 2, 2024 -- Johnson & Johnson announced Wednesday that it would pay out more than $6.5 billion over the next 25 years to settle existing...

No Sign of Bird Flu in Ground Beef, USDA Says

THURSDAY, May 2, 2024 -- After investigation, the U.S. Department of Agriculture said Wednesday that the nation's ground beef supply is so far testing...

U.S. Maternal Deaths Declined in 2022

THURSDAY, May 2, 2024 -- The number of American women who died at or soon after childbirth declined significantly in 2022, the latest government data shows...

Economy, Election Spur Rising Anxiety Among Americans in 2024

THURSDAY, May 2, 2024 -- A looming presidential election, continued economic struggles and the threat of gun violence have a rising number of Americans more...

Day Care Pick-Up Often Involves Sugary Snacks, Study Finds

THURSDAY, May 2, 2024 -- Giving your kid a drink, snack or small bag of fast food on the way home from day care might distract them during a busy commute, but...

Heart Health Varies With Race Among Sexual-Minority Females

WEDNESDAY, May 1, 2024 -- For sexual-minority (SM) females, cardiovascular health (CVH) varies across race and ethnicity, according to a study published online...

Pediatric Resource Use Less Likely With Legalization of Recreational Cannabis

WEDNESDAY, May 1, 2024 -- In cases of cannabis intoxication in children, resource utilization is less likely in states with recreational legalization of...

Healthy Lifestyle Can Overcome Genetic Predisposition to Premature Death

WEDNESDAY, May 1, 2024 -- Adherence to healthy lifestyles can largely overcome the genetic risk for a shorter lifespan, according to a study published online...

Brief Provocation of Anger Adversely Affects Endothelial Health

WEDNESDAY, May 1, 2024 -- A brief provocation of anger has an adverse effect on endothelial cell health, according to a study published online May 1 in the...

Following Drop After COVID-19 Onset, Inappropriate Antibiotic Prescribing Is Up

WEDNESDAY, May 1, 2024 -- There was an initial decrease in inappropriate antibiotic prescriptions following onset of COVID-19, followed by an increase...

Neurocrine Biosciences Announces U.S. FDA Approval of Ingrezza Sprinkle (valbenazine) Capsules

SAN DIEGO, April 30, 2024 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the U.S. Food and Drug Administration has approved...

FDA Approves Libervant (diazepam) Buccal Film for the Treatment of Seizure Clusters in Pediatric Patients Ages 2-5 Years

WARREN, N.J., April 29, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a...

FDA Approves Xolremdi (mavorixafor) for Use in Patients with WHIM Syndrome

BOSTON, April 29, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune...

FDA Grants Full Approval for Tivdak to Treat Recurrent or Metastatic Cervical Cancer

NEW YORK & COPENHAGEN, Denmark--(BUSINESS WIRE) April 29, 2024 -- Pfizer Inc. (NYSE: PFE) and Genmab A/S (Nasdaq: GMAB) today announced the U.S. Food and...

FDA Approves Hercessi (trastuzumab-strf), a Biosimilar to Herceptin

DURHAM, N.C., April 29, 2024 /PRNewswire/ -- Accord BioPharma, Inc., the U.S. specialty division of Intas Pharmaceuticals, Ltd., focused on the development of...

Abeona Therapeutics Provides Regulatory Update on Pz-cel

CLEVELAND, April 22, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced a regulatory update for prademagene zamikeracel (pz-cel)...

Supernus Provides Regulatory Update for SPN-830

ROCKVILLE, Md., April 08, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and...

Stealth Biotherapeutics Announces FDA Acceptance of New Drug Application for Elamipretide for the Treatment of Barth Syndrome

NEEDHAM, Mass., April 8, 2024 /PRNewswire/ — Stealth BioTherapeutics, a clinical-stage biotechnology company focused on the discovery, development and...

Jazz Pharmaceuticals Completes Zanidatamab Biologics License Application for Previously Treated HER2-Positive Metastatic Biliary Tract Cancer

DUBLIN, April 2, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company has completed the rolling submission of a...

Datopotamab Deruxtecan Biologics License Application Accepted in the US for Patients with Previously Treated Metastatic HR-Positive, HER2-Negative Breast Cancer

2 April 2024 -- AstraZeneca and Daiichi Sankyo’s Biologics License Application (BLA) for datopotamab deruxtecan (Dato-DXd) has been accepted in the US...

Gilgamesh Announces Initiation of Phase 2a Trial of GM-1020 in Major Depressive Disorder

NEW YORK, May 1, 2024. Gilgamesh Pharmaceuticals, a clinical-stage neuroscience company committed to developing best-in-class, rapid-acting treatments for...

Scientists Discover How an Essential Nutrient Enters the Brain

May 1, 2024 -- Researchers have discovered that choline, an essential nutrient vital for brain health, is actively transported from the bloodstream into the...

NRx Pharmaceuticals Announces Promising Findings in Phase 2b/3 Clinical Trial of NRX-101 vs. Lurasidone for Treatment of Suicidal Bipolar Depression

RADNOR, Pa., April 30, 2024, NRx Pharmaceuticals, Inc. ("NRx Pharmaceuticals", the "Company"), a clinical stage pharmaceutical company today that its...

Merck Announces Positive Data for V116, an Investigational, 21-Valent Pneumococcal Conjugate Vaccine Specifically Designed for Adults

RAHWAY, N.J.--(BUSINESS WIRE) April 29, 2024 -- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced results from...

Lower Dose of Mpox Vaccine is Safe and Generates Six-Week Antibody Response Equivalent to Standard Regimen

April 27, 2024 -- A dose-sparing intradermal mpox vaccination regimen was safe and generated an antibody response equivalent to that induced by the standard...

Browse by news type

Drugs.com Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.

Disclaimer

This library contains syndicated news articles. These articles have not been peer-reviewed by Drugs.com, and therefore we cannot guarantee accuracy to the highest ethical standards. Do further research as needed. Consultation with your physician is essential.